The incidence of tumor of anti-Amphiphysin antibody is 46 ~ 79%, which may be related to Sheehan syndrome, breast cancer, small-cell lung cancer, and angiosarcoma (Kelley et al. 2017). Here, AMPH is linked to breast carcinoma.